C. Donmez Et Al. , "Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?," SPRINGERPLUS , vol.5, 2016
Donmez, C. Et Al. 2016. Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?. SPRINGERPLUS , vol.5 .
Donmez, C., KONAÇ, E., Aydogan, B. T., & Bilen, C. Y., (2016). Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?. SPRINGERPLUS , vol.5.
Donmez, Cigdem Et Al. "Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?," SPRINGERPLUS , vol.5, 2016
Donmez, Cigdem Et Al. "Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?." SPRINGERPLUS , vol.5, 2016
Donmez, C. Et Al. (2016) . "Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?." SPRINGERPLUS , vol.5.
@article{article, author={Cigdem Donmez Et Al. }, title={Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?}, journal={SPRINGERPLUS}, year=2016}